FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study
Is a
Allocation Type
Randomized
0
Intervention Model
Single Group Assignment
0
Intervention Name
Placebo
0
INT-787
0
Interventional Trial Phase
Phase 2
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Drug
0
Last Updated
December 27, 2023
0
Masked Party
Participant
0
Care Provider
0
Investigator
0
Masking Type
Triple
0
Primary Completion Date
December 31, 2024
0
Trial Recruitment Size
50
0
Trial Sponsor
Clinical Trial Start Date
December 15, 2022
0
Study Completion Date
December 31, 2024
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-escalation, Proof-of-Concept Study Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetics of INT-787 in Subjects With Severe Alcohol Associated Hepatitis
0
Official Website
Find more entities like FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.